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Microvascular Resistance Predicts Myocardial Salvage and Infarct
Characteristics in ST-Elevation Myocardial Infarction
Alexander R. Payne, MRCP∗; Colin Berry, BSc, PhD, FRCP∗; Orla Doolin, MSc; Margaret McEntegart, MRCP, PhD; Mark C. Petrie, MD,
MRCP; M. Mitchell Lindsay, MD, MRCP; Stuart Hood, MD, MRCP; David Carrick, MRCP; Niko Tzemos, BSc(Hons), MRCP MD(Hons); Peter
Weale, BA, DCR(R); Christie McComb, MSc; John Foster, PhD; Ian Ford, PhD; Keith G. Oldroyd, MD(Hons), FRCP
Background—-The pathophysiology of myocardial injury and repair in patients with ST-elevationmyocardial infarction is incompletely
understood. We investigated the relationships among culprit artery microvascular resistance, myocardial salvage, and ventricular
function.
Methods and Results—-The index of microvascular resistance (IMR) was measured by means of a pressure- and temperature-
sensitive coronary guidewire in 108 patients with ST-elevation myocardial infarction (83% male) at the end of primary percutaneous
coronary intervention. Paired cardiac MRI (cardiac magnetic resonance) scans were performed early (2 days; n=108) and late (3
months; n=96) after myocardial infarction. T2-weighted- and late gadolinium–enhanced cardiac magnetic resonance delineated the
ischemic area at risk and infarct size, respectively. Myocardial salvage was calculated by subtracting infarct size from area at risk.
Univariable and multivariable models were constructed to determine the impact of IMR on cardiac magnetic resonance–derived
surrogate outcomes. The median (interquartile range) IMR was 28 (17–42) mm Hg/s. The median (interquartile range) area at
risk was 32% (24%–41%) of left ventricular mass, and the myocardial salvage index was 21% (11%–43%). IMR was a significant
multivariable predictor of early myocardial salvage, with a multiplicative effect of 0.87 (95% confidence interval 0.82 to 0.92)
per 20% increase in IMR; P<0.001. In patients with anterior myocardial infarction, IMR was a multivariable predictor of early
and late myocardial salvage, with multiplicative effects of 0.82 (95% confidence interval 0.75 to 0.90; P<0.001) and 0.92 (95%
confidence interval 0.88 to 0.96; P<0.001), respectively. IMR also predicted the presence and extent of microvascular obstruction
and myocardial hemorrhage.
Conclusion—-Microvascular resistance measured during primary percutaneous coronary intervention significantly predicts myocar-
dial salvage, infarct characteristics, and left ventricular ejection fraction in patients with ST-elevation myocardial infarction. ( J Am
Heart Assoc. 2012;1:e002246 doi: 10.1161/JAHA.112.002246)
Key Words: microcirculation  primary percutaneous coronary intervention  magnetic resonance imaging  myocardial
infarction  ventricular remodeling
S alvaging threatened myocardium after acute coronary oc-clusion is a key therapeutic objective,1 and the amount
of salvageable myocardium is an independent predictor of
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prognosis.2 Despite successful primary percutaneous coronary
intervention (PCI), at least one third of patients subsequently
develop microvascular obstruction that portends an adverse
prognosis.2,3
Ex vivo studies in experimental animals have suggested that
maintained microvascular patency in ischemic myocardium
limits infarct size.4 However, in vivo human studies are lack-
ing because it has not been possible to measure coro-
nary microvascular function directly. Standard clinical meth-
ods for assessing the efficacy of reperfusion, such as the
electrocardiogram5 and angiographic perfusion grade,6 are in-
direct and have limited diagnostic accuracy for culprit artery
microvascular function. Microvascular damage revealed non-
invasively by contrast-enhanced cardiac magnetic resonance
(CMR) imaging is an independent predictor of prognosis after
acute myocardial infarction (MI).3 However, because of issues
around feasibility and cost, CMR is not normally performed
early after MI. When CMR is available, it is usually performed
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up to 7 days after hospital admission in medically stabilized pa-
tients. Therefore, a direct quantitative measure of microvascu-
lar function during primary PCI would be an important advance
for very early risk stratification in routine clinical practice.
The index of microvascular resistance (IMR) is a sim-
ple coronary guidewire–based method for assessing coro-
nary microvascular function,7–11 including in patients with ST-
elevation MI (STEMI).10,11 IMR measured at the end of primary
PCI is an independent predictor of left ventricular ejection frac-
tion as measured by echocardiography10 or CMR11 3 months
after PCI. These observations suggest that IMR can be used to
study the pathophysiology of microvascular function in STEMI
and that IMR could have utility for very early prognostication.
Given that myocardial salvage can be measured with T2-
weighted CMR,2,12–16 we aimed to investigate the ability of
acutely measured IMR to predict subsequent myocardial sal-
vage and left ventricular remodeling in a cohort of patients with
STEMI. Our first hypothesis was that microvascular resistance
measured by IMR after culprit artery reperfusion is a determi-
nant of subsequentmyocardial salvage. Our second hypothesis
was that IMR is a predictor of left ventricular function during
follow-up. Our final hypothesis was that IMR would predict
the occurrence and severity of infarct characteristics, such as
myocardial hemorrhage and microvascular obstruction, which
have prognostic importance.2,3
Methods
Patient Population and STEMI Management
Consecutive acute STEMI patients undergoing primary PCI at
a regional cardiac center were screened. The inclusion criteria
were an indication for primary PCI for acute STEMI due to a his-
tory of symptoms consistent with acute myocardial ischemia
and with supporting changes on the electrocardiogram (ie, ST-
segment elevation or new left bundle-branch block).17 Exclu-
sion criteria represented standard contraindications to CMR,
including an estimated glomerular filtration rate <30 mL/min
per 1.73m2. The project was approved by theWest of Scotland
Research Ethics Committee.
Acute STEMI management followed contemporary
guidelines.17 Aspiration thrombectomy, direct stenting, an-
tithrombotic drugs, and other therapies were administered
according to clinical judgment.
IMR Measurement After Coronary Reperfusion
A coronary pressure- and temperature-sensitive guidewire (St
Jude Medical, Uppsala, Sweden) was used as the primary
guidewire. The guidewire was calibrated outside the body,
equalized with aortic pressure at the ostium of the guide
catheter, and then advanced to the distal third of the culprit
artery. IMR is defined as the distal coronary pressure multi-
plied by the mean transit time of a 3-mL bolus of saline at
room temperature during maximal coronary hyperemia, mea-
sured simultaneously (mm Hg · s, or units).7–11 Hyperemia was
induced by 140 μ/kg per minute of intravenous adenosine
preceded by a 2-mL intracoronary bolus of 200 μg nitrate.
The mean aortic and distal coronary pressures were recorded
during maximal hyperemia. Previous studies in patients with
stable coronary disease have established that IMR is repeat-
able and independent of hemodynamic variations, including
heart rate, blood pressure, and myocardial contractility.8,9 In
our study, the repeatability of IMR was assessed by duplicate
measurements 5 minutes apart in a subset of 12 consecutive
patients.
CMR Acquisition and Analyses
CMR was performed approximately 2 days after MI and 3
months after MI on a Siemens MAGNETOM Avanto (Erlangen,
Germany) 1.5-Tesla scanner with a 12-element phased-array
cardiac surface coil. The imaging protocol included cine MRI
with steady-state free precession, edema imaging with bright-
blood T2-weighted CMR,12,18,19 and delayed-enhancement
phase-sensitive inversion-recovery pulse sequences.20 The
bright-blood T2-weighted ACUT2E method (Acquisition for Car-
diac Unified T2 Edema)18,19 incorporates elements of the
bright-blood21 and turbo spin-echomethods.22 Typical imaging
parameters were as follows: acquisition time 7 to 12 seconds,
matrix 192×192, flip angle 180◦, echo time 1.69ms, and band-
width 789 Hz/pixel. Twenty-nine coherent spin echoes (echo
train length) were obtained per heartbeat, and the time interval
(echo spacing) between the 180◦ inversion pulses was 3.4 ms.
Data were acquired every second RR interval. The voxel size
was 1.9×1.9×6 mm3. Microvascular obstruction was defined
as a central dark zone on early delayed-enhancement imaging
1, 3, 5, and 7minutes after contrast injection andwithin an area
of late gadolinium enhancement (LGE). MI was imaged by using
a segmented phase-sensitive inversion-recovery turbo fast low-
angle shot18 radiofrequency pulse sequence 15 minutes after
intravenous injection of 0.10 mmol/kg gadoterate meglumine
(Gd2+-DOTA, Dotarem, Guebert S.A.). Typical imaging param-
eters were as follows: matrix 192×256, flip angle 25◦, echo
time 3.36 ms, bandwidth 130 Hz/pixel, echo spacing 8.7 ms,
and trigger pulse 2. The voxel size was 1.8×1.3×8 mm3.
MR Image Analyses
The images were analyzed on a Siemens workstation by 2
cardiologists (A.R.P., C.B.) with 3 and 5 years’ CMR expe-
rience, respectively.12,19,23 These cardiologists have consid-
erable CMR experience in patients with acute MI, including
protocols with bright-blood T2-weighted CMR. A third CMR
trained-cardiologist (N.T.) provided an independent opinion
when disagreement occurred, and agreement was established
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by consensus. All of the cardiologists were blinded to the
PCI and IMR results. Left ventricular dimensions, volumes,
and ejection fractions were quantified with computer-assisted
planimetry.
Reference ranges used in the laboratory were 105 to 215 g
for left ventricular mass in men, 70 to 170 g for left ventricular
mass in women, 77 to 195 mL for left ventricular end-diastolic
volume in men, 52 to 141 mL for left ventricular end-diastolic
volume in women, 19 to 72 mL for left ventricular end-systolic
volume in men, and 13 to 51mL for left ventricular end-systolic
volume in women.
Myocardial Edema and Standardized
Measurements of T2-Weighted Area at Risk
Quantitative assessments were performed by 2 independent
observers, and their results were averaged. The approach to
image analysis, including interobserver agreement, has been
reported previously.12,19 The jeopardized area at risk on each
axial image was defined as the percentage of left ventricu-
lar area delineated by the hyperintense zone on T2-weighted
images.12,19
Infarct Definition and Size
The presence of acute infarction was established with CMR on
the basis of abnormalities in cine wall motion, rest first-pass
myocardial perfusion, and LGE imaging. In addition, support-
ing changes on the electrocardiogram and coronary angiogram
were required. Acute infarction was considered present only if
LGE was confirmed on both the short- and long-axis acquisi-
tions. The myocardial mass of LGE (in grams) was quantified
by a semiautomatic detection method that used a signal inten-
sity threshold of >2 standard deviations (SDs) above a remote
reference region.11,15,19 Infarct regions with evidence of mi-
crovascular obstruction were included within the infarct area.
Microvascular obstruction was classified as relevant (central
dark zone with a subendocardial or intramural distribution) or
nonrelevant (dots or nil) and also was expressed as a percent-
age of total left ventricular mass.
Myocardial Salvage
Myocardial salvage was calculated by subtraction of percent
infarct size from percent area at risk.12 The myocardial salvage
index was calculated by dividing the myocardial salvage area
by the initial area at risk.
Definition and Detection of Hemorrhage on
T2-Weighted CMR
Myocardial hemorrhage revealed by bright-blood T2-weighted
CMR was defined as a confluent dark zone with a mean signal
intensity <2 SDs of the mean signal intensity of the surround-
ing affected brighter area.23 Hemorrhage was expressed as a
percentage of total left ventricular mass.
Angiographic Analyses
All angiograms were analyzed by 2 interventional cardiologists
independent of theCMRanalyses. The Thrombolysis InMyocar-
dial Infarction (TIMI) flow classification24 and corrected TIMI
frame count25 were used to grade culprit artery flow at initial
angiography and at the end of the PCI. The TIMI myocardial
perfusion grade was used to assess myocardial perfusion.26
Statistical Analyses
The primary end point was myocardial salvage index. The sam-
ple size estimate was based on the adjusted effect (multi-
ple regression) for the relationship between IMR measured
acutely and myocardial salvage index as revealed by contrast-
enhanced CMR, after adjustment for prespecified known prog-
nostic clinical confounders. In multiple-regression models for
myocardial salvage index, 80 subjects would provide ≥80%
power to detect a correlation of 0.3 with a type 1 error rate
of 0.05. With allowance for occasional problems with data
acquisition, the projected sample size was ≥100 subjects.
All subjects with available data were used in models fitted
for CMR parameters at initial and follow-up scans. Normality
was assessed by using the Shapiro-Wilk test. Means and SDs
were used to summarize normally distributed data, geometric
means and SDs to describe skewed data, percentages to sum-
marize distributions, and Pearson coefficients (r) to describe
correlations between log IMR and CMR parameters. Normal
distributions were achieved where necessary by logarithmic
transformation. All tests were 2 tailed, with a significance level
of 0.05.
Between-group comparisons of continuous variables used
Student t tests or Mann-Whitney tests, whereas differences in
proportions were assessed with either a Fisher exact test or
a χ2 test with continuity correction, as appropriate. Random-
effects models were used to compute interrater reliability mea-
sures (intraclass correlation coefficient [ICC]) for CMR param-
eters measured independently by 2 observers in 20 randomly
selected patients. Univariable and multivariable regression
models were constructed to determine the prognostic signifi-
cance of IMR with CMR parameters: myocardial salvage index,
infarct size, microvascular obstruction, hemorrhage, area at
risk, and left ventricular ejection fraction and volumes. Further
subgroup analysis explored patients with and without a culprit
left anterior descending coronary artery at initial angiography
and patients with and without an occluded culprit coronary
artery. We used a backward variable selection process with the
cut point of 0.1 to select variables for the final multivariable
models. IMR was specified in each multivariable model, but
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because renal function and serum troponin are not available at
the time of primary PCI when IMR is measured, these variables
were not included. Multivariable models adjusted for variables
in stepwise selection models. For all baseline CMR outcomes,
adjustment was made for the following variables: previous MI,
sex, pain-to-balloon time, door-to-balloon time, thrombectomy,
catheterization laboratory pulse pressure, TIMI flow, corrected
TIMI frame count, and percent of ST elevation still present after
PCI. For all follow-up CMR outcomes, we adjusted for baseline
value of the CMR parameter, age, door-to-balloon time, gly-
coprotein IIb/IIIa, TIMI flow, and percent of ST elevation still
present after PCI.
IMR associations were described by an effect estimate (ei-
ther additive or multiplicative) on the continuous CMR param-
eters per 20% increase in IMR, with 95% confidence intervals
(CIs) and P values. All statistical analyses were performed in
SAS (SAS Institute, Cary, NC).
Results
Patient Characteristics
One hundred eight patients with acute STEMI treated by pri-
mary PCI were enrolled between October 1, 2009, and July 8,
2010 (Table 1). Forty-seven patients (44%) had anterior STEMI,
and 61 patients (56%) had nonanterior MI (P=0.1). IMR was
measured at the end of primary PCI in all patients. Intravenous
adenosine was well tolerated in all patients, and there were no
adverse events. All patients were alive after 3 months’ follow-
up.
IMR Immediately After Primary PCI
Repeated IMR measurements obtained by 4 different oper-
ators in 12 STEMI patients were highly correlated (r=0.99,
P<0.001), with a mean difference between IMR measure-
ments of 0.01 (mean standard error 1.59 [95% CI −3.52 to
3.54], P=0.48). The median (interquartile range) IMR in all pa-
tients was 28 (17–42) mm Hg/s, with a range of 9 to 149
mm Hg/s. IMR correlated with time from symptom onset
to coronary reperfusion (r=0.22, P=0.021). The median (in-
terquartile range) arterial pressure measured simultaneously
with IMR was 79.5 (69.5–97.0) mm Hg. Arterial pressure and
IMR were not correlated (r=0.17, P=0.10).
The Figure 1 illustrates observations in a patient with infero-
lateral STEMI, including the IMR value measured at the end of
primary PCI and subsequentmyocardial salvage by CMR2 days
later.
CMR Findings
One hundred eight patients underwent CMR an average of 2
days after primary PCI. Ninety-six patients (89%) returned for a
Table 1. Baseline Characteristics of Patients With Acute
STEMI and a CMR Scan at Baseline (n=108)
Age, y 57.8±10.2
Body mass index, kg/m2∗ 26 (23–30)
Heart rate, bpm 76±16
Systolic blood pressure, mm Hg∗ 131 (113–149)
Diastolic blood pressure, mm Hg∗ 80 (66–91)
Pain-to-balloon time, min∗ 186 (137–331)
IMR, mm Hg/s∗ 26 (17–41)
Sex, male 90 (83.3)
Previous MI 4 (3.7)
Diabetes mellitus 5 (4.6)
Sustained ventricular arrhythmias or clinical signs of
acute left ventricular failure
18 (16.7)
Culprit artery
Left anterior descending 47 (43.5)
Circumflex 13 (12)
Right coronary artery 48 (44.4)
Killip class
I 96 (88.8)
II 2 (1.9)
III 9 (8.3)
IV 1 (1)
TIMI grade before PCI
0/1 70 (65)
2 22 (20)
3 16 (15)
TIMI grade after PCI
0/1 1 (1)
2 9 (8)
3 98 (91)
Data are given as mean±SD, n (%), or
∗median (interquartile range).
CMR was performed during the index hospitalization (n=108) and 3 months afterward
(n=96). The clinical characteristics of the patients with paired CMR scans at baseline
and at follow-up (n=96) were similar to those of patients with a single scan at baseline
(n=108).
follow-up scan ≈3 months later (Table 2). The baseline charac-
teristics of the patients who did or did not attend the 3-month
follow-up MRI scan were similar. In an assessment of inter-
observer agreement, 20 patients were randomly selected for
independent analysis by 2 observers. ICCs indicated a high de-
gree of reliability: left ventricular ejection fraction, ICC=0.97;
left ventricular end-diastolic volume, ICC=0.98; left ventricu-
lar end-systolic volume, ICC=0.98; and infarct size, ICC=0.99.
The median (interquartile range) initial area at risk estimated
by bright-blood T2-weighted CMR was 32% (24%–41%) of left
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Figure 1. A 60-year-old man presented with an acute infero-lateral STEMI. Primary PCI to the occluded left circumflex artery included aspiration
thrombectomy, intravenous tirofiban, and implantation of a bare metal stent. The initial 0.014-inch coronary guidewire was exchanged for a
pressure wire (Certus, St Jude Medical, Uppsala, Sweden), and intravenous adenosine (140 μg/kg per minute) was administered.
On the RADIView recording (top), Pa (red) is the aortic pressure measured from the guide catheter; Pd (green), the distal coronary pressure
measured from the distal end of the pressure wire; and FFR (yellow), the fractional flow reserve derived from Pa divided by Pd. These parameters
are depicted in the upper graph (Y-axis left is pressure [mm Hg]; Y-axis right is units). The lower graph displays coronary thermodilution curves
measured with the microelectrode at the distal end of the pressure- and temperature-sensitive Certus wire. The thermodilution curves are blue
under resting conditions and yellow during hyperemia. The distal coronary pressure was 87 mm Hg, the mean hyperemic transit time was
0.78 seconds, and the IMR was 68 mm Hg seconds, which is markedly elevated. Two days later, CMR was performed. Cine MRI (lower left)
revealed an infero-lateral left ventricular wall motion abnormality. Matched diastolic phase images obtained by using bright-blood T2-weighted
CMR (lower middle, red arrows) and LGE imaging (lower right, yellow arrows) revealed transmural edema and infarction, respectively. The area at
risk revealed by bright-blood T2-weighted CMR (lower middle) was 58% of left ventricular mass. Infarct size revealed by LGE (lower right) was 57%,
consistent with 1% of salvageable myocardium. The central dark zone within the infarct territory represents extensive confluent microvascular
obstruction complicated by myocardial hemorrhage, indicative of severe MI. The microvascular obstruction was confirmed in orthogonal long-axis
views (not shown). The initial left ventricular ejection fraction and normalized end-systolic volume were 49% and 39 mL/m2, respectively. Three
months later, the left ventricular ejection fraction remained reduced (51%), and the normalized left ventricular end-systolic volume had increased
to 44 mL/m2, consistent with adverse left ventricular remodeling.
ventricular mass, and the myocardial salvage index was 21%
(11%–43%) (Table 2). The area at risk was greater in patients
with anterior MI than in patients with nonanterior MI (mean
difference 11.1% of left ventricular mass [95% CI 6.7 to 15.5],
P<0.001).
Microvascular Resistance and CMR Findings
Early (2 Days) After MI
The patients were divided into quartiles according to IMR.
With higher values of IMR, the area at risk and initial infarct
size increased and left ventricular ejection fraction decreased
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Table 2. CMR Findings in 96 Patients With a Paired CMR
Scan at Baseline and at Follow-Up
MRI findings during index hospitalization
Area at risk, % 32.9±12.4
Infarct size, % 23.5±14.2
Myocardial salvage index, %∗ 19.2±36.3
Microvascular obstruction, n (%) 38 (40)
Microvascular obstruction, %∗ 3.1±2.9
Myocardial hemorrhage, n (%) 44 (47)
Myocardial hemorrhage, % of left ventricle∗ 2.5±1.9
Left ventricular mass, g
Men 141.6±27.4
Women 101.0±23.0
Left ventricular ejection fraction, % 51.3±10.0
Left ventricular end-diastolic volume, mL
Men 165.6±31.8
Women 125.9±33.3
Left ventricular end-systolic volume, mL
Men 83.1±24.6
Women 57.1±29.1
MRI findings at 3 months
Myocardial salvage index, %∗ 42.11±47.5
Infarct size, % 16.6±11.6
Left ventricular ejection fraction, % 56.9±9.9
Left ventricular end-diastolic volume, mL
Men 174.0±39.4
Women 129.6±37.8
Left ventricular end-systolic volume, mL
Men 79.5±33.6
Women 51.5±31.8
Data are given as n (%) or mean±SD.
∗Values are geometric mean±SD.
The CMR findings in patients with paired scans (n=96) were similar to those of patients
with a single scan at baseline (n=108).
(Table 3). Median (interquartile range) IMR was higher in pa-
tients with myocardial hemorrhage than in those with no hem-
orrhage: 29.1 (18.2–46.5) versus 17.1 (13.2–23.5); P=0.006.
IMR correlated positively with the presence of microvascular
obstruction (r=0.38, P<0.001) and with myocardial hemor-
rhage (r=0.43, P<0.001) and negatively with myocardial sal-
vage index (r=−0.38, P<0.001).
Microvascular Resistance and CMR Findings Late
(3 Months) After MI
At 3 months, IMR correlated negatively with left ventricular
ejection fraction (r=−0.27, P=0.009) and positively with left
ventricular end-systolic volume (r=0.24, P=0.019).
Univariable and Multivariable Relationships
Between IMR and Infarct Characteristics
IMR was a univariable predictor of area at risk and early infarct
size, myocardial salvage, microvascular obstruction, hemor-
rhage, and left ventricular ejection fraction. IMR was a uni-
variable predictor of infarct size and left ventricular ejection
fraction at 3 months (Table 4). At 2 days, multivariable mod-
els confirmed significant predictive effects of IMR on initial
injury characteristics, including area at risk, infarct size, my-
ocardial salvage, microvascular obstruction, and myocardial
hemorrhage (Table 5). At 3 months, after adjustment for val-
ues at 2 days, IMR continued to show a significant predictive
effect on infarct size. In separate linear models of IMR and
initial infarct size, microvascular obstruction, and hemorrhage,
and after adjustment for left ventricular mass, IMR was more
closely associated with infarct size (data not shown) than with
either hemorrhage or microvascular obstruction (P<0.001 for
both comparisons).
Patients With Anterior or Nonanterior Infarcts
In a comparison of patients with anterior and nonanterior in-
farctions (Table 6), IMR was a multivariable predictor of early
Table 3. CMR at Day 2 by Quartiles of IMR Measured at the End of Primary PCI
Quartiles of IMR
1 2 3 4 P† P Trend
(≤17) (18–27) (28–42) (>42)
Area at risk, % 30.0±12.4 28.8±11.6 31.2±11.5 38.2±12.2 0.036† 0.020
Infarct size, % 17.3±13.1 18.1±13.0 24.5±12.0 31.7±13.0 0.001‡ <0.001
Myocardial salvage index, %∗ 28.3±40.2 17.5±48.2 21.3±37.6 14.3±24.8 0.338‡ <0.001
Left ventricular ejection fraction, % 53.6±8.4 54.3±10.3 51.0±9.8 46.1±9.3 0.017† 0.005
Data are mean±SD, P value for group differences, and P value for test of trend.
∗Values are geometric mean±SD calculated from the log-transformed distributions.
†P values from analysis of variance.
‡P values from Kruskal-Wallis tests.
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Table 4. Estimated Effects on CMR Parameters Associated
With a 20% Increase in IMR (mm Hg/s) Derived From
Univariable Models
r Effect 95% CI P
of IMR
Univariable associations, early CMR (2 days)
Area at risk, % 0.29 1.07 0.39 to 1.76 0.003
Infarct size, % 0.45 1.84 1.12 to 2.56 <0.001
Myocardial
salvage index,
%
−0.41 −3.42 −4.93 to −1.92 <0.001
Microvascular
obstruction, %
0.35 0.37 0.18 to 0.56 <0.001
Hemorrhage, % 0.43 0.28 0.17 to 0.40 <0.001
Left ventricular
ejection
fraction, %
−0.27 −0.80 −1.35 to −0.24 0.005
Univariable associations, late CMR (3 months)
Infarct size, % 0.34 1.13 0.48 to 1.79 <0.001
Myocardial
salvage index,
%
−0.31 −2.46 −4.01 to −0.92 0.002
Left ventricular
ejection
fraction, %
−0.27 −0.77 −1.34 to −0.20 0.009
Results are Pearson correlation coefficients (r) and additive effects.
infarct characteristics, including infarct size, myocardial sal-
vage, microvascular obstruction, and myocardial hemorrhage,
in both groups. In patients with anterior MI, at 3 months, af-
ter adjustment for initial CMR findings, IMR predicted infarct
size, myocardial salvage, and left ventricular ejection fraction
(Table 6).
Patients With Occluded or Patent Culprit Arteries
at Presentation
In a comparison of patients with an occluded culprit artery
(TIMI flow grade 0/1) at initial presentation to those with a
patent culprit artery (TIMI flow grade 2/3) (Table 7), IMR was a
multivariable predictor of early infarct characteristics, includ-
ing infarct size, microvascular obstruction, and hemorrhage, in
both groups. At 3 months, IMR predicted myocardial salvage
in patients with an occluded artery but not after adjustment
for the initial extent of salvage (data not shown).
Microvascular Resistance and Left Ventricular
Remodeling
Multivariable models with left ventricular end-diastolic and
end-systolic volumes at 3 months showed no association
Table 5. Estimated Effects on CMR Parameters Associated
With a 20% Increase in IMR (mm Hg/s) Derived From
Multivariable Models With Adjustment for Confounders at
Both Time Points
IMR 95% CI P
Effect
Multivariable associations,∗ early CMR (2 days)
Area at risk, % 0.98 0.33 to 1.64 0.004
Infarct size, % 1.68 1.01 to 2.34 <0.001
Myocardial salvage index, % −3.43 −4.86 to −2.00 <0.001
Microvascular obstruction, % 0.21 0.02 to 0.40 0.028
Hemorrhage, % 0.19 0.08 to 0.31 0.002
Left ventricular ejection
fraction, %
−0.64 −1.16 to −0.12 0.017
Multivariable associations,† late CMR (3 months)
Infarct size, % −0.08 −0.47 to 0.31 0.680
Myocardial salvage index, % −0.19 −1.31 to 0.94 0.744
Left ventricular ejection
fraction, %
−0.19 −0.56 to 0.18 0.315
Results are additive effects on the CMR parameter.
∗For all baseline CMR outcomes, adjustment was made for the following variables:
previous MI, sex, pain-to-balloon time, door-to-balloon time, thrombectomy,
catheterization laboratory pulse pressure, TIMI flow, corrected TIMI frame count, and
percent of ST elevation still present after PCI.
†For all follow-up CMR outcomes, we adjusted for baseline value of the CMR parameter,
age, door-to-balloon time, glycoprotein IIb/IIIa, TIMI flow, and percent of ST elevation
still present after PCI.
with IMR after adjustment for initial volumes (Tables 5, 6,
and 7).
Discussion
Our results indicate that after primary PCI for STEMI, microvas-
cular resistance assessed by IMR is a significant predictor of
myocardial salvage. Second, microvascular resistance was as-
sociated significantly with left ventricular ejection fraction in all
patients initially and in patients with anteriorMI after 3months’
follow-up. Finally, in addition to predicting myocardial salvage,
microvascular resistance was a significant predictor of sev-
eral infarct characteristics, including infarct size, microvascu-
lar obstruction, and myocardial hemorrhage. Importantly, IMR
provided additive predictive value to established measures of
coronary/myocardial reperfusion, including time to reperfu-
sion, coronary flow grades, and electrocardiogram changes.
IMR adds early prognostic information at the key time of emer-
gency reperfusion therapy when CMR is not possible, and,
potentially, IMR represents a measurable therapeutic target
after coronary reperfusion in STEMI.
Because microvascular resistance significantly predicted
initial myocardial salvage, we conclude that microvascu-
lar patency is a key pathophysiological determinant of the
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Table 6. Comparison of Anterior and Nonanterior Infarctions: Estimated Effects on CMR Parameters Associated With a 20%
Increase in IMR (mm Hg/s)
Anterior STEMI (n=47) Nonanterior STEMI (n=61)
IMR Effect (95% CI) P IMR Effect (95% CI) P
Multivariable associations,∗ early CMR (2 days)
Infarct size, % 2.11 (0.89 to 3.32) 0.001 1.38 (0.64 to 2.12) <0.001
Myocardial salvage index, % −3.97 (−6.16 to −1.78) <0.001 −3.28 (−5.12 to −1.43) <0.001
Microvascular obstruction, % 0.37 (0.10 to 0.64) 0.009 0.14 (−0.09 to 0.38) 0.225
Hemorrhage, % 0.26 (0.08 to 0.44) 0.006 0.18 (0.03 to 0.32) 0.019
Left ventricular ejection fraction, % −0.76 (−1.77 to 0.26) 0.145 −0.62 (−1.10 to −0.13) 0.016
Multivariable associations,† late CMR (3 months)
Infarct size, % −0.08 (−0.77 to 0.61) 0.812 0.04 (−0.41 to 0.48) 0.894
Myocardial salvage index, % −1.07 (−2.95 to 0.81) 0.266 0.10 (−1.32 to 1.52) 0.892
Left ventricular ejection fraction, % −0.89 (−1.53 to −0.26) 0.008 0.02 (−0.40 to 0.44) 0.921
Results are additive effects on the CMR parameters.
∗For all baseline CMR outcomes, adjustment was made for the following variables: previous MI, sex, pain-to-balloon time, door-to-balloon time, thrombectomy, catheterization laboratory
pulse pressure, TIMI flow, corrected TIMI frame count, and percent of ST elevation still present after PCI.
†For all follow-up CMR outcomes, we adjusted for baseline value of the CMR parameter, age, door-to-balloon time, glycoprotein IIb/IIIa, TIMI flow, and percent of ST elevation still present
after PCI.
injury/repair response in the infarcted human heart. This ob-
servation is a new insight into the pathophysiology of MI and is
consistent with previous experimental observations in large an-
imal models.4 Independent of other early predictors of myocar-
dial salvage, such as time to reperfusion and initial infarct size,
our findings suggest that microvascular function influences the
balance between recovery of viable injured tissue and progres-
sive infarction. The pathophysiology of microvascular injury in
STEMI is complex and encompasses embolization of proximal
thrombus and in situ microvascular thrombosis, as well as ex-
travascular pathologies such as edema and hemorrhage.27 We
also have demonstrated for the first time that microvascular
resistance shortly after coronary reperfusion is associated with
subsequent evidence ofmyocardial hemorrhage as revealed by
CMR, consistent with the notion that hemorrhage is an adverse
complication of more severe MI.
Table 7. Comparison of Patients With Occluded (TIMI 0/1) and Patent (TIMI 2/3) Culprit Arteries at Presentation: Estimated
Effects on CMR Parameters Associated With a 20% Increase in IMR (mm Hg/s)
Patients With an Occluded Culprit Artery(n=70) Patients With a Patent Culprit Artery(n=38)
IMR Effect (95% CI) P IMR Effect (95% CI) P
Multivariable associations,∗ early CMR (2 days)
Infarct size, % 1.56 (0.69 to 2.43) <0.001 1.97 (0.94 to 2.99) <0.001
Myocardial salvage index, % −3.68 (−5.26 to −2.11) <0.001 −3.10 (−5.88 to −0.32) 0.034
Microvascular obstruction, % 0.26 (0.01 to 0.51) 0.041 0.11 (−0.09 to 0.31) 0.270
Hemorrhage, % 0.28 (0.13 to 0.44) <0.001 0.15 (0.01 to 0.28) 0.043
Left ventricular ejection fraction, % −0.72 (−1.38 to −0.07) 0.032 −0.65 (−1.57 to 0.27) 0.168
Multivariable associations,† late CMR (3 months)
Infarct size, % 0.27 (−0.12 to 0.67) 0.176 −0.36 (−1.10 to 0.38) 0.344
Myocardial salvage index, % −1.11 (−2.34 to 0.12) 0.079 1.09 (−1.03 to 3.21) 0.318
Left ventricular ejection fraction, % −0.32 (−0.77 to 0.14) 0.173 0.14 (−0.50 to 0.78) 0.663
Results are additive effects on the CMR parameters. Results at 3 months are adjusted for the initial value of the outcome being analyzed.
∗For all baseline CMR outcomes, adjustment was made for the following variables: previous MI, sex, pain-to-balloon time, door-to-balloon time, thrombectomy, catheterization laboratory
pulse pressure, TIMI flow, corrected TIMI frame count, and percent of ST elevation still present after PCI.
†For all follow-up CMR outcomes, we adjusted for baseline value of the CMR parameter, age, door-to-balloon time, glycoprotein IIb/IIIa, TIMI flow, and percent of ST elevation still present
after PCI.
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Our study extends the results of Fearon et al,10 who found
that IMR predicted left ventricular wall motion score at 3
months after MI in 28 STEMI patients, as well as our own
data in a prior study of a separate cohort of patients in whom
CMR was used to assess ventricular function.11 Our present
study confirms these observations in a much larger cohort
but also demonstrates that microvascular resistance predicts
infarct characteristics, including initial microvascular obstruc-
tion and infarct size, especially in patients with anterior MI or
an occluded artery.
Intuitively, it makes sense that IMR did not predict final left
ventricular ejection fraction in all patients because its predic-
tive value is most likely to be discriminative in patients with
large infarctions. For example, a small MI might have little
impact on systolic function (eg, occlusion of a left ventricu-
lar branch of the right coronary artery) even if microvascular
injury is pronounced within distribution of the culprit artery.
One other explanation could be that because the sample size
is relatively small, there might have been insufficient power to
detect a true inverse association between IMR and ejection
fraction. We also found that IMR was more closely associated
with infarct size than with microvascular injury (ie, microvascu-
lar obstruction or myocardial hemorrhage). Because IMR was
performed before CMR, we cannot say whether infarct burden
is a determinant of microvascular dysfunction or vice versa.
However, IMR also correlated with the extent of microvascular
obstruction and hemorrhage, which points to the pathological
importance of the extent and not just the presence of these
abnormalities.3
The accuracy and precision of IMR has been established
in patients with stable coronary artery disease, but its perfor-
mance in STEMI has not been fully explored.9 We found that
IMR was highly repeatable when measured twice 5 minutes
apart at the end of primary PCI.
We have shown that IMR is predictive of myocardial hemor-
rhage as revealed by bright-blood T2-weighted CMR.23 In the
current study, IMR was nearly 2-fold higher in patients with
myocardial hemorrhage than in patients without hemorrhage.
Myocardial hemorrhage could represent an unintended con-
sequence of evidence-based antithrombotic and antiplatelet
therapies, a manifestation of more severe MI (as suggested by
our data), or both. Our other main finding is that early myocar-
dial salvage is a significant predictor of subsequent changes
in left ventricular function. This result complements the co-
hort study by Dall’Armellina et al,15 who performed serial CMR
scans in 30 STEMI patients over 6 months of follow-up and
found that regression in infarct size during follow-up predicted
the recovery in wall motion. Taken together, both studies indi-
cate that the propensity for improvement in the initial extent
of injury (ie, myocardial repair and salvage) is a determinant of
future changes in left ventricular systolic function. On the basis
of our findings,microvascular patencymight permit recovery of
salvageable myocardium, whereas microvascular injury might
predispose to limited salvage and impaired systolic function in
the longer term.
Our results raise the possibility that microvascular injury
might be a measurable therapeutic target after coronary reper-
fusion in STEMI. For this to be the case, IMR should identify
patients who might benefit from a specific treatment. Ideally,
the treatment should be given at the time of primary PCI, lead-
ing to a measurable reduction in IMR or an improvement in
prognostically important surrogate measures of microvascu-
lar injury.4–6 Results from preliminary therapeutic trials during
primary PCI for STEMI support the notion that microvascular
injury is a therapeutic target.28–30
Limitations
Microvascular patency is only one of several characteristics
that influence myocardial salvage and systolic function after
MI, and our multivariable models account for only part of this
variability, as reflected by the R2 values. We could have used a
larger signal intensity difference between remote and affected
myocardium on LGE CMR to delineate infarct area, but we be-
lieve that the main conclusions in our analysis remain valid.
Although IMR a multivariable predictor of left ventricular vol-
umes after 3 months, this was not the case after adjustment
for volumes measured early after MI. The predictive value of
IMR for adverse remodeling needs further prospective study in
a larger cohort.
Conclusions
Microvascular function is a determinant of myocardial salvage
in patients with reperfused STEMI and predicts changes in left
ventricular function and remodeling. IMR seems to be most
informative in patients with an anterior MI or occluded culprit
artery.
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